Identifying costs associated with parenteral nutrition
Posted in News
While there are some commercially manufactured standard products such as Intralipid and Vamin for patients requiring parenteral nutrition, more than 80% of the total spend in this area is on patient-specific products.
Patient-specific products are not represented on dm+d and as they are not mapped to dm+d, they also do not have the associated BNF or ATC codes.
In order for Trusts to be able to monitor spend on parenteral nutrition products, all identified commercial products used as ingredients in parenteral nutrition (including supplements such as Additrace) and all patient-specific products have been assigned a Flag ‘Parenteral Nutrition’. Selecting this Flag in the search dialogue box will ensure that the costs associated with parenteral nutrition products (N.B. but not associated compounding, delivery or set up fees) are correctly identified. This will be important in understanding complete PbR-excluded spends.